Xiangwei Xu

614 total citations
41 papers, 482 citations indexed

About

Xiangwei Xu is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Xiangwei Xu has authored 41 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pharmacology. Recurrent topics in Xiangwei Xu's work include Natural product bioactivities and synthesis (7 papers), Phytochemistry and Biological Activities (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Xiangwei Xu is often cited by papers focused on Natural product bioactivities and synthesis (7 papers), Phytochemistry and Biological Activities (4 papers) and Pharmacological Effects of Natural Compounds (3 papers). Xiangwei Xu collaborates with scholars based in China, United States and Finland. Xiangwei Xu's co-authors include Lisa Ebihara, Eric C. Beyer, Viviana M. Berthoud, Xiaodan Wang, Hua Lin, Ling Li, C Oberti, Zhenkun Li, Lihui Gao and Jun Chen and has published in prestigious journals such as Biophysical Journal, Molecules and European Journal of Pharmacology.

In The Last Decade

Xiangwei Xu

40 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangwei Xu China 9 245 94 68 64 45 41 482
Xuekai Wang China 10 170 0.7× 90 1.0× 40 0.6× 42 0.7× 43 1.0× 17 388
Qun Du China 14 349 1.4× 53 0.6× 91 1.3× 39 0.6× 38 0.8× 23 543
Shuo Yuan China 13 237 1.0× 53 0.6× 94 1.4× 39 0.6× 37 0.8× 31 490
Nagaraj M. Kulkarni India 13 151 0.6× 86 0.9× 25 0.4× 34 0.5× 47 1.0× 19 410
Xinghui Wang China 14 209 0.9× 145 1.5× 30 0.4× 62 1.0× 21 0.5× 31 549
Sungmin Bae South Korea 12 241 1.0× 78 0.8× 29 0.4× 50 0.8× 22 0.5× 38 521
S. Choudhary United States 8 260 1.1× 112 1.2× 60 0.9× 26 0.4× 25 0.6× 9 577
Eun Suk Ha South Korea 9 299 1.2× 69 0.7× 47 0.7× 21 0.3× 23 0.5× 11 512
Mohamed A. Shaheen Egypt 15 265 1.1× 56 0.6× 25 0.4× 39 0.6× 32 0.7× 41 623
Youra Kang South Korea 13 272 1.1× 56 0.6× 58 0.9× 102 1.6× 25 0.6× 27 579

Countries citing papers authored by Xiangwei Xu

Since Specialization
Citations

This map shows the geographic impact of Xiangwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangwei Xu more than expected).

Fields of papers citing papers by Xiangwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangwei Xu. The network helps show where Xiangwei Xu may publish in the future.

Co-authorship network of co-authors of Xiangwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangwei Xu. A scholar is included among the top collaborators of Xiangwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangwei Xu. Xiangwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiabao, Yuanlong Zhang, Xiao‐Quan Xu, et al.. (2025). Neuroprotective effect of apo-9′-fucoxanthinone against cerebral ischemia injury by targeting the PI3K/AKT/GSK-3β pathway. European Journal of Pharmacology. 991. 177348–177348. 1 indexed citations
2.
3.
4.
Liu, Weizhen, Zongliang Xiao, Lei Li, et al.. (2023). Selective enrichment strategy induces ultra-broadband NIR emission in Cr3+-doped multi-phase glass-ceramics for NIR spectroscopy applications. Ceramics International. 49(23). 38318–38330. 8 indexed citations
5.
Chen, Jiahao, Wu Luo, Chenghong Hu, et al.. (2023). Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis. International Immunopharmacology. 118. 110065–110065. 3 indexed citations
6.
Zheng, Hongmei, et al.. (2023). Lysosome and related protein degradation technologies. Drug Discovery Today. 28(11). 103767–103767. 5 indexed citations
7.
Xu, Xiangwei, et al.. (2023). Ginsenoside Rg5 alleviates Ang II–induced cardiac inflammation and remodeling by inhibiting the JNK/AP-1 pathway. International Immunopharmacology. 120. 110408–110408. 18 indexed citations
8.
Zeng, Shenxin, Ming Zeng, Jian‐Dong Huang, et al.. (2023). Discovery of potent and selective HPK1 inhibitors based on the 2,4-disubstituted pyrimidine scaffold with immune modulatory properties for ameliorating T cell exhaustion. Bioorganic Chemistry. 139. 106728–106728. 8 indexed citations
9.
Xiao, Zongliang, Li Lei, Xiuxun Han, et al.. (2023). High-performance luminescence of europium ion-activated Na2O-CaO-SiO2 system glass-ceramics through component regulation and crystallization process optimization strategies. Materials Characterization. 207. 113463–113463. 9 indexed citations
10.
Ma, Ji, et al.. (2023). Dehydrovomifoliol Alleviates Nonalcoholic Fatty Liver Disease via the E2F1/AKT/mTOR Axis: Pharmacophore Modeling and Molecular Docking Study. Evidence-based Complementary and Alternative Medicine. 2023(1). 9107598–9107598. 4 indexed citations
11.
Li, Ruya, et al.. (2023). Network pharmacology analysis of the pharmacological mechanism of Artemisia lavandulaefolia DC. in rheumatoid arthritis. Phytomedicine. 118. 154905–154905. 5 indexed citations
12.
13.
Xu, Xiangwei, et al.. (2022). Phytochemical investigation of the fruits of Xanthium strumarium and their cytotoxic activity. Journal of Natural Medicines. 76(2). 468–475. 5 indexed citations
14.
Xu, Xiangwei, et al.. (2022). New prenylated flavonoid glycosides from the stems of Celastrus orbiculatus with their anti-tumor activities. Natural Product Research. 37(9). 1463–1469. 4 indexed citations
15.
Xu, Fang, et al.. (2021). Resveratrol Alleviates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice by Mediating PI3K/Akt/VEGFA Pathway. Frontiers in Pharmacology. 12. 693982–693982. 38 indexed citations
16.
Xu, Xiangwei, et al.. (2021). (+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway. Frontiers in Pharmacology. 12. 750147–750147. 15 indexed citations
17.
Xu, Xiangwei, et al.. (2021). Phenolic and Acid Derivatives from Artemisia sieversiana. Chemistry of Natural Compounds. 57(2). 250–253. 2 indexed citations
18.
Mou, Yanhua, Siyuan Wang, Xiaoxiao Gao, et al.. (2021). Design, synthesis and biological evaluation of selective histone deacetylase 6 (HDAC6) inhibitors bearing benzoindazole or pyrazoloindazole scaffold as surface recognition motif. Bioorganic Chemistry. 111. 104910–104910. 3 indexed citations
19.
Chen, Jun, et al.. (2021). New flavonoid glycosides from Xanthium strumarium with their protein tyrosine phosphatase 1B inhibitory activity. Journal of Asian Natural Products Research. 24(1). 45–51. 5 indexed citations
20.
Xu, Xiangwei, Viviana M. Berthoud, Eric C. Beyer, & Lisa Ebihara. (2002). Functional Role of the Carboxyl Terminal Domain of Human Connexin 50 in Gap Junctional Channels. The Journal of Membrane Biology. 186(2). 101–112. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuekai Wang Breakdown of academic impact, for papers by Qun Du Breakdown of academic impact, for papers by Shuo Yuan Breakdown of academic impact, for papers by Nagaraj M. Kulkarni Breakdown of academic impact, for papers by Xinghui Wang Breakdown of academic impact, for papers by Sungmin Bae Breakdown of academic impact, for papers by S. Choudhary Breakdown of academic impact, for papers by Eun Suk Ha Breakdown of academic impact, for papers by Mohamed A. Shaheen Breakdown of academic impact, for papers by Youra Kang
Rankless by CCL
2026